Table 2.
Comparison between polyposis and healthy participants.
| Group | Normal | Polyposis | Difference (95% CI) | p-Value |
|---|---|---|---|---|
| (n = 20) | (n = 86) | |||
| Age (years), mean (SD) | 37.12 (12.8) | 49.57 (12.76) | <0.001 | |
| Sex (F), n (%) | 8 (40) | 29 (33.72) | 0.596 | |
| Smoking, n (%) | 3 (15) | 20 (23.25) | 0.554 | |
| Asthma, n (%) | 0 (0) | 28 (32.55) | 0.010 | |
| Allergy, n (%) | 0.09 | |||
| Environmental | 3 (15) | 18 (20.93) | ||
| NSAIDs | 0 (0) | 14 (16.28) | ||
| No | 17 (85) | 54 (62.79) | ||
| miR-125, median (IQR) | 0.4 (0.3–0.64) | 1.19 (0.88–1.85) | 0.74 (−1.08–−0.53) | <0.001 |
| miR-203, median (IQR) | 1.42 (0.78–2.97) | 0.4 (0.26–0.62) | 1.02 (0.59–1.37) | <0.001 |
SD, standard deviation; IQR, interquartile range; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs; miR, micro-ribonucleic acid.